News & More

Latest news, analysis, and opinions related to digital health ecosystem in Europe.

    Bactolife gets €30M to commercialise its proprietary Binding Proteins technology
    Proceeds from the financing will enable Bactolife to advance its most mature projects towards commercial launch and strengthen the technology platform and upscaling capabilities. By doing so, the company aims at retaining its first mover advantage to transform human and animal health with target specific Binding Proteins.
    KetoSwiss raises $4.8M in 2nd closing of its pre-series A round
    The company intends to use the funds to expand R&D and clinical development efforts of its brain energetics products based on ketone bodies. KetoSwiss’ flagship product MigraKet a dietary-preventive therapy for migraine and related diseases that are characterized by metabolic dysfunction.
    Luxembourg’s accelerator Fit 4 Start #14 is now open
    It is looking for innovative and sustainable ventures whose business integrates dimensions related to one or several of the three main pillars of sustainability, namely people, planet, and prosperity. The 14th edition of the program will provide the right tools and support to maximize the startup's chances for commercial success in and out of Luxembourg. Fit 4 Start has dedicated tracks for healthtech and space startups.
    CathVision secures $9M for its ECGenius System and CARDIALYTICS AI-Suite
    The financing will help advance commercial operations driving adoption of the ECGenius System, the company’s innovative EP recording technology, and support the continued development of artificial intelligence-powered analytic modules to provide electrophysiologists with unprecedented levels of automated analysis during cardiac ablation procedures. This includes expansion of the company’s sales team and U.S. presence, and further ...
    Germany’s biotech firm AATec Medical raises €2.7M in Seed financing
    AATec Medical is developing a multi-product platform based on recombinant alpha-1 antitrypsin (AAT). It will use the funds to scale up its technology, expand the team and prepare for clinical studies expected to start in 2024. The first product candidate, ATL-105, is a novel AAT formulation for inhalation to treat emerging inflammatory diseases of the lung and respiratory virus infections.
    OrganOx gets £25M for its transportable, automated ex vivo liver perfusion device
    The proceeds will enable OrganOx to significantly expand its commercial footprint across strategically key areas of the business. This includes expanding the customer-facing team in the United States due to high interest and adoption of the OrganOx technology. In addition, the investment will be made in new infrastructure to facilitate and accelerate programs within the R&D pipeline.
    France’s EG 427 raises an additional €5M, completes its Series A
    The round, which brought the total amount to €18M, saw participation from a combination of existing and new family office investors. Paris, France-based biotechnology company developing pinpoint DNA medicine solutions will use the funds to finance the clinical development of its lead product EG110A and advance other pipeline products.
    Tenpoint Therapeutics launches with $70M Series A financing to reverse vision loss
    Tenpoint Therapeutics is a biotechnology company that was established based on the pioneering work of its scientific founders from Moorfields Eye Hospital, University College London Institute of Ophthalmology, Institut de la Vision in Paris, and the University of Washington, who have developed engineered cell-based therapeutics and performed translational research to establish proof-of-concept. Based on these foundational achievements, Tenpoint is advancing approaches to generate specialized ocular cell types both ex vivo and in vivo.
    France’s Sonio raises $14M for its AI prenatal screening solution
    The company has developed an AI-powered prenatal screening solution that automates ultrasound reporting, ensuring healthy pregnancies worldwide. Sonio will use the funds to fuel improvements to the SaaS solution, initiate its commercial development in the United States, and adapt its technology for the use of portable ultrasound scanners "providing image quality control and detection of potential anomalies using AI."
    Jared Kushner’s Affinity Partners invests in smart fitness startup EGYM
    The Munich-based company raised €207 million ($225 million) on the back of a solid year of growth. EGYM's business includes a line of connected hardware (gym equipment); software (apps and diagnostics to measure and optimize how people work out on connected fitness equipment); a corporate health network operation called Wellpass with more than 2.5 million users; and a mission: to improve healthcare outcomes by focusing on "the shared economy of a gym," in the words of CEO and co-founder Philipp Roesch-Schlanderer.
Quick Search